As of October 2024 BridgeBio Pharma has a market cap of A$6.53 Billion. This makes BridgeBio Pharma the world's 2970th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Oct 9th, 2024 the market cap of BridgeBio Pharma was reported to be: